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Abstract—The clonal selection principle explains the basic
features of an adaptive immune response to a antigenic stimulus.
It established the idea that only those cells that recognize the
antigens are selected to proliferate and differentiate. This paper
explains a computational implementation of the clonal selection
principle that explicitly takes into account the affinity maturation
of the immune response. Antibodies generated by the clonal
selection algorithm are clustered in some categories according
to the affinity maturation, so that immunological memory cells
which respond to the specified pathogen are created. Experimen-
tal results to classify the medical database of Coronary Heart
Disease databases are reported. For the dataset, our proposed
method shows the 99.6% classification capability of training data.
I. INTRODUCTION
In a few decades, the area of artificial immune system (AIS)
has been an ever-increasing interested in not only theoret-
ical works but applications in pattern recognition, network
security, and optimization [1],[2],[3],[4],[5],[6],[7]. AIS uses
ideas gleaned from immunology in order to develop adaptive
systems capable of performing a wide range of tasks in various
research areas.
The biological basis of the Clonal Selection Theory was
proposed by Burent [8],[9] in 1959. The theory interprets the
response of lymphocytes in the face of antigenic stimulus.
Only the immune cells with high affinity are selected to
proliferate, while those low affinity cells must be efficiently
deleted or become anergic. The hypermutation is allowed
to improve the affinity of the selected cells to the selective
antigens. Receptor Editing as a mechanism of immune cell
tolerance is reported [10],[11],[12].
Gao indicated the complementary roles of somatic hyper-
mutation (HM) and receptor editing (RE) and presented a
novel clonal selection algorithm called RECSA model by
incorporating the Receptor Editing method [13]. In [13],
they discussed the relationship between HM and RE through
utilizing them to solve the TSPs. Because a valid tour in TSP
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is represented by a permutation of N cities, the number of
states to feasible tours is (N − 1)! [1] solves the problems for
finding an optimal set in the search space consisted of the set
of (N − 1)! valid tours in TSPs.
A gene structure to classify the Coronary Heart Disease
database (CHD DB)[14] by using RECSA model was devel-
oped in [15]. The classification of medical database differs
from the TSP, because medical information such as results
of biochemical tests and chief complaint is often ambiguous.
Therefore, we cannot clearly distinguish the difference be-
tween normal and pathological values. Biochemical test values
cannot be precisely evaluated by using crisp sets. An output
in the database is summed up all the inputs modified by their
respective weights and is compared with the corresponding
teach signal. If the summation of weighted input is larger
than a certain threshold, the antibody respond to the training
sample. We consider that the threshold value is important to
classify the samples. Therefore, the memory cells are trained
to respond to the specified samples according to the threshold
values. In order to the effectiveness of the proposed method,
we challenge the computational classification results of the
databases. The database consists of Train A, X, Y, and Z and
one testing dataset. Our proposed method has the extraordinary
power, since the simulation results shows 99.6% classification
capability of the training dataset, Train A.
The remainder of this paper is organized as follows. In
Section II, the clonal selection theory will be explained briefly.
Section III will explain RECSA model proposed in [13]. The
response by memory cells will be discussed in Section IV.
Experimental results for classification of the medical database
will be reported in Section V. In Section VI, we give some
discussions to conclude this paper.
II. THE CLONAL SELECTION THEORY
Burnet proposed the clonal selection theory in order to
explain the essential features of adaptive immune response
[8][9]. The basic idea of this theory interprets the response of
lymphocytes in the face of an antigenic stimulus.
Any molecule that can be recognized by the adaptive
immune system is known as antigens (Ags). Some subpopula-
tions of its bone-marrow-derived cells responds by producing
antibody (Ab). Abs are molecules attached primarily to the
surface of B cells. The aim of B cell is to recognize and bind
to Ags. Each B cell (B lymphocytes) secretes a single type of
Ab. By binding to these Abs and with a second signal from
T-helper cell, the Ag stimulates the B cell to proliferate and
mature into terminal Ab secreting cells called plasma cells.
Proliferation of the B cell is a mitotic process whereby the
cells divide themselves, creating a set of clones identical to
the parent cell. The proliferation rate is directly proportional
to the affinity level. That is, the higher affinity level of B
cells, the more of them will be readily selected for cloning
and cloned in larger numbers.
In addition to proliferating and differentiating into plasma
cells, B cells can differentiate into long lived B memory cells.
Memory cells circulate through the blood, lymph, and tissues.
By exposing to a second antigenic stimulus, they commence
to differentiate into plasma cells capable of producing high
affinity Abs, which are preselected for the specific Ag that
stimulated the primary response.
Gao has been proposed the clonal selection method by in-
corporating receptor editing which can diversify the repertoire
of antigen activated B cells during asexual reproduction [13].
The method has two mechanisms of somatic hypermutation
and receptor editing [16][17][18].
III. CLONAL SELECTION ALGORITHM WITH
IMMUNOLOGICAL MEMORY
Clonal Selection Algorithm with Immunological Mem-
ory(CSAIM) model has been proposed to introduce an idea of
immunological memory into the RECSA model. This section
describes the structure of antibody in RECSA model to the
medical diagnosis briefly.
A. RECSA Model[13]
The shape-space model aims at quantitatively describing the
interactions among Ags and Abs (Ag-Ab) [19],[20]. The set of
features that characterize a molecule is called its generalized
shape. The Ag-Ab codification determines their spatial repre-
sentation and a distance measure is used to calculate the degree
of interaction between these molecules.
The Gao’s model [13] can be described as follows.
1) Create an initial pool of m antibodies as candidate
solutions(Ab1 ,Ab2 , · · · ,Abm).
2) Compute the affinity of all antibodies:
(D(Ab1 ), D(Ab2 ), · · · , D(Abm)). D() means
the function to compute the affinity.
3) Select n best individuals based on their affinities
from the m original antibodies. These antibodies
will be referred to as the elites.
4) Sort the n selected elites in n separate and distinct
pools in ascending order. They will be referred to
as the elite pools.
5) Clone the elites in the pool with a rate proportional
to its fitness. The amount of clone generated for
these antibodies is given by Eq.(1).
Pi = round(
n− i
n
×Q) (1)
i is the ordinal number of the elite pools, Q
is a multiplying factor for determining the scope
of the clone and round() is the operator that
rounds towards the closest integer. Then, we can
obtain
∑
Pi antibodies as ((Ab1 ,1 ,Ab1 ,2 , · · · ,
Ab1 ,p1 ), · · · , (Abn,1 ,Abn,2 , · · · ,Abn,pn )).
6) Subject the clones in each pool through either
hypermutation or receptor editing process. The mu-
tation rates, Phm for hypermutation and Pre for
receptor editing given by Eq.(2) and Eq.(3), are
inversely proportional to the fitness of the parent
antibody,
Phm = a/D() (2)
Pre = (D()− a)/D(), (3)
where D() is the affinity of the current parent
antibody and a is an appropriate numerous value.
7) Determine the fittest individualBi in each elite pool
from amongst its mutated clones. The Bi is satisfied
with the following equation.
D(Bi) = max(D(Abi,1 ), · · · , D(Abi,pi )),
i = 1, 2, · · · , n (4)
8) Update the parent antibodies in each elite pool
with the fittest individual of the clones and the
probability P (Abi ,→ Bi) is according to the roles:
if D(Abi) < D(Bi) then P = 1, if D(Ab1 ) ≥
D(B1) then P = 0, if D(Abi) ≥ D(Bi), i 6= 1
then P = exp(D(Bi)−D(Abi)
α
).
9) Replace the worst c(= βn, βisarbitraryvalue.)
elite pools with new random antibodies once every
t generations to introduce diversity and prevent the
search from being trapped in local optima.
10) Determine if the maximum number of generation
Gmax to evolve is reached. If it is satisfied with
this condition, it terminates and returns the best
antibody. Otherwise, go to Step 4).
1) Structure of Antibody to Medical Diagnosis: Fig.1 shows
the structure of antibody in the classification problem of Heart
Disease Database[14]. Each of the data sets consists of ten data
items as shown in Table I.
2) Somatic Hypermutation and Receptor Editing: HM up-
dates the randomly selected wi and θ for a paratope P =
(w1, ..., wk, θ) as follows.
wi = wi +∆w, θ = θ +∆θ,
where ∆w, ∆θ are −γw < ∆w < γw, −1 < ∆θ < γθ,
respectively.
RE makes a crossover of 2 set of wi for a paratope as shown
in Fig.2.
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Fig. 1. The antibody structure
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Fig. 2. RE for w2, wk−1
3) Affinity: The system calculates the degree of affinities
between antibody and antigen by using Eq.(5) and Eq.(6).
f(xp) =
{
1 if |
∑k
i=1 wix
P
i − θ| ≥ Esim
0 otherwise
(5)
g(xp) =
{
1 if f(xp) = xpCHD
0 otherwise
(6)
Eq.(7) calculates the degree of affinity.
Affinity =
tr num∑
p=1
g(xp), (7)
where xp means the pth sample in tr num training cases and
xpCHD is 1 if an example is a CHD, otherwise 0.
IV. IMMUNOLOGICAL MEMORY CELL
A. Clustering Memory Cell
Clustering Memory Cells is required to classify the anti-
bodies responding the specified samples. This paper realizes
the clustering by allocating the generated antibodies RECSA
model into some categories. The initial number of categories is
predefined and a new category is created according to training
situation. Fig. 4 shows the clustering method of memory cells.
Similar antibodies crowd around an appropriate point in each
category, and then only central antibody of the crowd can
become a memory cell. However, we may meet that memory
cells can not recognize some of samples in the dataset. In such
a case, some new generated antibodies by RECSA model tries
to respond to the misclassification of the samples, if the similar
antibodies make a crowd.
To find the crowd of similar cases, the system checks
whether the Euclidean distance between normalized training
sample and its corresponding antibody is smaller than the
predetermined parameter µθ.
The similarity is measured by the following. Let ~d =
(d1, · · · , di, · · · , dk) be the elements of input signal and ~h =
(h1, · · · , hi, · · · , hk) be the element of antibody.
In order to calculate the distance between the sample and the
antibody, the range of sample is changed to that of antibody
as follows.
d
′
i = di ×
hj
dj
(di 6= 0 ∧ hi 6= 0) (8)
dj is the min value of element in the input sample.
Then, if the Euclidean distance between ~d′ and ~h is smaller
than µθ , the antibody can respond the sample. In this paper,
µθ is the summation of 8 input elements.
B. Training Memory Cell
Fig.3 shows the immune process of CSAIM model. The
learning algorithm in CSAIM is as follows.
1) Select the elite antibody without improving the de-
gree of affinity during τ generations.
2) Let Tro be training cases that g(x
p) in Eq.(6) equals
to 0. T numro is the number of training cases in Tro .
3) For each training case in Tro , calculate the output
of the selected individual by using the following
equation.
O =
k∑
i=1
wixi, (9)
where wi is a weight for each paratope.
4) Calculate the difference δ by using output value and
θ.
E =
1
2
δ2 =
1
2
(θq − O)
2, (10)
where q(1 ≤ q ≤ IM) means the cluster of memory
cells.
5) Update weights.
wi = wi + ηδxi, (11)
where η takes a real value in [0.1, 1.0].
6) The procedure from 3 to 5 is executed for all the cases
in Tro till the given number of iterations reaches, TIM
or error Emin becomes less than the expected value.
The good antibodies after training are recorded in the
memory.
Fig. 5. The learning algorithm of CSAIM
V. EXPERIMENTAL RESULTS
A. Database Design
The CHD DB is designed to reproduce the original data of
the Framingham Heart Study. Requisite information is derived
from the reports on six-year follow-up in the Framingham
Heart Study [22],[23].
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Fig. 6. Prognostic System for the development of CHD
Table I shows the data items of the CHD DB. Each of the
datasets consists of ten data items: ID, development of CHD,
and eight items that were collected from the initial examination
(i.e. baseline data). The eight items; ORIGIN, EDUCATE, TO-
BACCO, ALCHOL, SBP, DBP, TC, and LVH, were examined
whether it was associated with the development of CHD over
six-year follow-up in the Framingham Heart Study. Using the
CHD DB, researchers will develop a prognostic system that
will discriminate between those who developed CHD (CHD
cases) and those who did not (Non-CHD cases) on the basis
of the eight data items as shown in Fig.6.
The CHD DB consists of four training datasets (Train A,
X, Y, and Z) and one testing dataset (Test) as shown in
Fig.7. We previously reported that the developed prognostic
system highly depended on the quality of training dataset [24].
The small proportion of cases to non-cases in the training
dataset might contribute to a poor learning about the cases,
TABLE I
DATA ITEMS OF CORONARY HEART DISEASE DATABASE
Data Item Name Value
ID ID Sequential Value
Development of CHD CHD 0=No; 1= Yes
National Origin ORIGIN 0=Native-born; 1=Foreign-born
Education EDUCATE 0=Grade School; 1=High School, not graduate; 2=High School. graduate; 3=College
Tobacco TOBACCO 0=Never; 1=Stopped; 2=Cigars or Pipes; 3=Cigarettes(<20/day); 4=Cigarettes(≤20/day)
Alcohol ALCOHOL Continuous Value(oz/mo)
Systolic Blood Pressure SBP Continuous Value (mmHg)
Diastolic Blood Pressure DBP Continuous Value (mmHg)
Cholesterol TC Continuous Value (mg/dl)
Left Ventricular Hypertrophy LVH 0=None; 1=Definite or Possible
Train_A
and Test
(n=13,000)
Non-CHD
Cases
CHD
Cases
Train_X
(n=19,500)
Train_Y
(n=65,000)
Train_Z
(n=4,000)
Fig. 7. Training and test datasets
and consequently, the developed prognostic system might have
lack of ability to identify potential cases from the population
at risk. Therefore, the four training datasets are designed
to have different proportions of CHD cases to Non-CHD
cases. The number of combination of the eight data items is
expected to be about six and a half thousand: 2 (ORIGIN)
× 4 (EDUCATE) × 5 (TOBACCO) × 3 (ALCOHOL) × 3
(SBP) × 3 (DBP) × 3 (TC) × 2 (LVH) = 6,480, where the
numerical data are counted as three. In the original data of
the Framingham Heart Study, the number of complete records
was about four thousand and the proportion of CHD cases to
Non-CHD cases in men aged 45 or older was about one to
nine (i.e. the six-year incidence of CHD was 9.1%). Therefore,
Train A, Train X, and Train Y include 6,500 CHD cases and
6,500 (× 1), 13,000 (× 2), and 585,000 (× 9) Non-CHD cases,
respectively, while Train Z approximates to the original data
both for the number of total records and the proportion of CHD
cases to Non-CHD cases. On the other hand, for the testing
dataset, we prepared 6,500 CHD cases and 6,500 Non-CHD
cases separately from the training datasets.
B. Experimental Results
In this paper, we examined the classification capability to
Train A and Test. The parameters in the experiments are
defined as follows: Gmax = 100,m = 150, n = 100, Q = 50,
HM : RE = 1 : 1. −1 ≤ rw ≤ 1, −1 ≤ rθ ≤ 1.
Esim = 0.05, t = 10, e = 10 described in Section IV.
Furthermore, to improve the calculation speed, we set the fol-
lowing parameters: the training ratio of memory cells, η = 0.1;
the Euclidean distance between a sample and an antibody
representing the similarity, µθ = 0.3; the number of iterations
of training memory cells, tIM = 50; the stop condition of
training memory cells, Emin = 0.001; the maximum size of
memory cells, cmemorymax =
1
2n.
Table II was the comparison result of Train A dataset and
TEST dataset for the average of 10 runs. The RECSA and
CSAIM mean the traditional method and our proposed method,
respectively. The classification result shows that our proposed
method has better capability power than the traditional method.
TABLE II
CORRECT RATIO
Train A TEST
RECSA 62.3% 58.7%
CSAIM 99.6% 99.4%
Fig. 8 shows the correct ratio of training samples at each
generation. We can understand that our proposed method can
recognize the different patterns even to the patterns which
the traditional method cannot classify. Thus, the extraordinary
higher capability power can show the good performance of
classification of CHD DB.
Fig. 9 shows the change of increase of Immunological
Memory Cells. From the Fig. 8 and Fig. 9, the more memory
cells are generated within the maximum size of memory, the
classification capability becomes higher.
Furthermore, the calculation speed of our proposed method
has been reduced by more than half. Because the system
can search an antibody corresponded to the antigen by using
memory cells after a period of training, but the system has to
generate many antibodies in the initial phase of training.
VI. CONCLUSIVE DISCUSSION
The clonal selection principle established the idea that
only those cells that recognize the antigens are selected to
proliferate and differentiate. The method by [13], RECSA,
explicitly takes into account the affinity maturation of the
immune response by incorporating receptor editing method. In
this paper, the immunological memory cells are realized in the
RECSA model. A gene structure to classify the Coronary heart
disease database (CHD DB)[14] by using RECSA model was
developed. The memory cells in some categories are trained
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to respond to the specified samples according to the simi-
larities between antigen and antibody. As the computational
classification results of Train A in CHD DB, the classification
capability was about 99.6% correct ratio of test dataset. We
will examine the other datasets in CHD DB.
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